Clinical Trials Browser

Phase 1/2 × OTHER × Metastatic Pancreatic Adenocarcinoma × Clear all

NCT02324543 2023-07-21

Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer

Phase 1/2 Completed

47 enrolled 22 charts

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT02562898 2021-05-06

Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer

Phase 1/2 Completed

18 enrolled 15 charts

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma